Literature DB >> 20553963

Improved assessment of laser-induced choroidal neovascularization.

Hassanain S Toma1, Joshua M Barnett, John S Penn, Stephen J Kim.   

Abstract

The primary objective of this study was to develop and evaluate new methods of analyzing laser-induced choroidal neovascularization (CNV), in order to make recommendations for improving the reporting of experimental CNV in the literature. Six laser burns of sufficient power to rupture Bruch's membrane were concentrically placed in each eye of 18 adult Norway rats. Eyes received intravitreal injections of either triamcinolone acetonide, ketorolac, or balanced salt solution (BSS). Fluorescein angiography (FA) was performed 2 and 3 weeks after injection, followed by choroidal flat mount preparation. Vascular leakage on FAs and vascular budding on choroidal mounts were quantified by measuring either the cross-sectional area of each CNV lesion contained within the best-fitting polygon using Adobe Photoshop (Lasso Technique or Quick Selection Technique), or the area of bright pixels within a lesion using Image-Pro Plus. On choroidal mounts, the Lasso Technique and Image-Pro Plus detected a significant difference in lesion size between either ketorolac or triamcinolone when compared to BSS, while the Quick Selection Technique did not (Lasso Technique, 0.78 and 0.64; Image-Pro Plus, 0.77 and 0.65). On FA, the Lasso Technique and Quick Selection Technique detected a significant difference in lesion size between either ketorolac or triamcinolone when compared to BSS, while Image-Pro Plus did not (Lasso Tool, 0.81 and 0.54; Quick Selection Tool, 0.76 and 0.57). Choroidal mounts and FA are both valuable for imaging experimental CNV. Adobe Photoshop and Image-Pro Plus are both able to detect subtle differences in CNV lesion size, when images are not manipulated. The combination of choroidal mounts and FA provides a more comprehensive assessment of CNV anatomy and physiology.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20553963      PMCID: PMC3390000          DOI: 10.1016/j.mvr.2010.05.011

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  50 in total

1.  Photodynamic therapy in practice: a review of the results of the first 12 months experience with verteporfin at the Royal Victorian Eye and Ear Hospital.

Authors:  Rohan W Essex; Salmaan H Qureshi; Melinda S Cain; C Alex Harper; Robyn H Guymer
Journal:  Clin Exp Ophthalmol       Date:  2003-12       Impact factor: 4.207

2.  Long-term effectiveness of photodynamic therapy by using a hydrophilic photosensitizer ATX-S10(Na) against experimental choroidal neovascularization in rats.

Authors:  M Kanai; A Obana; Y Gohto; S Nagata; T Miki; K Kaneda; S Nakajima
Journal:  Lasers Surg Med       Date:  2000       Impact factor: 4.025

3.  Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model.

Authors:  T A Ciulla; M H Criswell; R P Danis; T E Hill
Journal:  Arch Ophthalmol       Date:  2001-03

4.  Laser targeted photo-occlusion of rat choroidal neovascularization without collateral damage.

Authors:  Hirokazu Nishiwaki; Ran Zeimer; Morton F Goldberg; Salvatore A D'Anna; Stanley A Vinores; Rhonda Grebe
Journal:  Photochem Photobiol       Date:  2002-02       Impact factor: 3.421

Review 5.  Angioid streaks.

Authors:  J G Clarkson; R D Altman
Journal:  Surv Ophthalmol       Date:  1982 Mar-Apr       Impact factor: 6.048

Review 6.  Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study.

Authors:  P Mitchell; W Smith; K Attebo; J J Wang
Journal:  Ophthalmology       Date:  1995-10       Impact factor: 12.079

7.  Effect of COX inhibitors on VEGF-induced retinal vascular leakage and experimental corneal and choroidal neovascularization.

Authors:  Marisol R Castro; David Lutz; Jeffrey L Edelman
Journal:  Exp Eye Res       Date:  2004-08       Impact factor: 3.467

8.  An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice.

Authors:  Jayakrishna Ambati; Akshay Anand; Stefan Fernandez; Eiji Sakurai; Bert C Lynn; William A Kuziel; Barrett J Rollins; Balamurali K Ambati
Journal:  Nat Med       Date:  2003-10-19       Impact factor: 53.440

9.  Verteporfin photodynamic therapy in the rat model of choroidal neovascularization: angiographic and histologic characterization.

Authors:  David N Zacks; Eric Ezra; Yoshiko Terada; Norman Michaud; Edward Connolly; Evangelos S Gragoudas; Joan W Miller
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-07       Impact factor: 4.799

10.  Topical nepafenac inhibits ocular neovascularization.

Authors:  Kyoichi Takahashi; Yoshitsugu Saishin; Yumiko Saishin; Keisuke Mori; Akira Ando; Satoru Yamamoto; Yuji Oshima; Hiroyuki Nambu; Michele B Melia; David P Bingaman; Peter A Campochiaro
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-01       Impact factor: 4.799

View more
  14 in total

1.  Objective area measurement technique for choroidal neovascularization from fluorescein angiography.

Authors:  Micah J Guthrie; Christian R Osswald; Nicole L Valio; William F Mieler; Jennifer J Kang-Mieler
Journal:  Microvasc Res       Date:  2013-12-05       Impact factor: 3.514

2.  Reduced choroidal neovascular membrane formation in cyclooxygenase-2 null mice.

Authors:  Kasra A Rezaei; Hassanain S Toma; Jiyang Cai; John S Penn; Paul Sternberg; Stephen J Kim
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-03       Impact factor: 4.799

3.  Pathogenic role of the Wnt signaling pathway activation in laser-induced choroidal neovascularization.

Authors:  Yang Hu; Ying Chen; Mingkai Lin; Kyungwon Lee; Robert A Mott; Jian-xing Ma
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-07       Impact factor: 4.799

4.  Heparanase-1 activities in the development of laser induced choroidal neovascularization.

Authors:  Wei-Qiang Tang; Bao-Ke Hou
Journal:  Int J Ophthalmol       Date:  2013-04-18       Impact factor: 1.779

5.  A Quantitative and Standardized Method for the Evaluation of Choroidal Neovascularization Using MICRON III Fluorescein Angiograms in Rats.

Authors:  Jonathan P Wigg; Hong Zhang; Dong Yang
Journal:  PLoS One       Date:  2015-05-29       Impact factor: 3.240

6.  Improvement and optimization of standards for a preclinical animal test model of laser induced choroidal neovascularization.

Authors:  Yanji Zhu; Qing Lu; Jikui Shen; Ling Zhang; Yushuo Gao; Xi Shen; Bing Xie
Journal:  PLoS One       Date:  2014-04-29       Impact factor: 3.240

7.  Substance P promotes the recovery of oxidative stress-damaged retinal pigmented epithelial cells by modulating Akt/GSK-3β signaling.

Authors:  Sang-Min Baek; Seung-Young Yu; Youngsook Son; Hyun Sook Hong
Journal:  Mol Vis       Date:  2016-08-12       Impact factor: 2.367

8.  Highly potent VEGF-A-antagonistic DARPins as anti-angiogenic agents for topical and intravitreal applications.

Authors:  Andreas Stahl; Michael T Stumpp; Anja Schlegel; Savira Ekawardhani; Christina Lehrling; Gottfried Martin; Maya Gulotti-Georgieva; Denis Villemagne; Patrik Forrer; Hansjürgen T Agostini; H Kaspar Binz
Journal:  Angiogenesis       Date:  2012-09-15       Impact factor: 9.596

9.  Imaging evidence of diabetic choroidopathy in vivo: angiographic pathoanatomy and choroidal-enhanced depth imaging.

Authors:  Rui Hua; Limin Liu; Xinling Wang; Lei Chen
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

10.  LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling.

Authors:  Stephen E Moss; John Greenwood; Xiaomeng Wang; Sabu Abraham; Jenny A G McKenzie; Natasha Jeffs; Matthew Swire; Vineeta B Tripathi; Ulrich F O Luhmann; Clemens A K Lange; Zhenhua Zhai; Helen M Arthur; James Bainbridge
Journal:  Nature       Date:  2013-07-18       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.